Records containing: Neuroblastoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-05-18Prognostic Impact of Segmental Chromosome Aberrations in Non MYCN Amplified Neuroblastomas in Different Age Groups
-
CLINICAL_TRIALS study record update · 2016-05-18Neuropeptide Y and Its Receptors in Neuroblastoma
-
CLINICAL_TRIALS study record update · 2016-05-18Therapeutically Applicable Research to Generate Effective Treatments (TARGET) for Neuroblastoma
-
CLINICAL_TRIALS study record update · 2016-05-18The Role of Stroma-Derived Soluble TßRIII in Neuroblastoma
-
CLINICAL_TRIALS study record update · 2016-05-17Analysis of Intersectin Expression in Primary Human Neuroblastomas
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-05-17Genome Based Outcome Prediction in High Risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2016-04-15ROR1 as a Novel Target for Neuroblastoma
-
CLINICAL_TRIALS study record update · 2016-03-02A Phase I/II Study of LDE225 in Pediatric Patients With Recurrent or Refractory Medulloblastoma or Other Tumors Potentially Dependent on the Hedgehog-signaling Pathway and Adult Patients With Recurrent or Refractory Medulloblastoma
-
CLINICAL_TRIALS study record update · 2016-02-10A Phase 1/1B Dose-Escalation Study to Determine the Safety and Tolerability of SCH 717454 Administered in Combination With Chemotherapy in Pediatric Subjects With Advanced Solid Tumors (Protocol No. 05883)
-
CLINICAL_TRIALS study record update · 2016-02-09A Phase I/II Study of MLN8237, an Oral Selective Small Molecule Inhibitor of Aurora A Kinase, in Children With Relapsed/Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2016-01-26Phase 2 Single- Arm Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Neuroblastoma and Other Paediatric Solid Tumours
-
CLINICAL_TRIALS study record update · 2016-01-21A Phase I, Open-Label, Dose Escalation Study of JX-594 (Vaccinia GM-CSF/Thymidine Kinase-Deactivated Virus) Administered by Intratumoral Injection in Pediatric Patients With Unresectable Refractory Solid Tumors.
-
CLINICAL_TRIALS study record update · 2016-01-07A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2015-12-03Dose Intensive Chemotherapy for Children Less Than Ten Years of Age Newly-Diagnosed With Malignant Brain Tumors: A Pilot Study of Two Alternative Intensive Induction Chemotherapy Regimens, Followed by Consolidation With Myeloablative Chemotherapy (Thiotepa, Etoposide and Carboplatin) and Autologous Stem Cell Rescue
-
CLINICAL_TRIALS study record update · 2015-11-26A Phase 2b Study Evaluating the Efficacy and Safety of Ultratrace™ Iobenguane I 131 Among Patients With Relapsed/Refractory High-Risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2015-11-25Phase II Study of Arsenic Trioxide in Neuroblastoma and Other Pediatric Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-10-16A Multicenter Pilot Study of Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation With In-vivo T-cell Depletion to Evaluate the Role of NK Cells and KIR Mis-matches in Relapsed or Refractory High-risk Neuroblastoma.
-
CLINICAL_TRIALS study record update · 2015-09-28Combination of Targeted I -3F8-Mediated Radioimmunotherapy and Bevacizumab in Patients With Relapsed or Refractory Neuroblastoma: A Phase I Study
-
CLINICAL_TRIALS study record update · 2015-09-23A Comparative Pharmacokinetic and Safety Study of Chimeric Monoclonal Antibody ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), Interleukin-2 (IL-2) and Isotretinoin in High Risk Neuroblastoma Patients Following Myeloablative Therapy
-
CLINICAL_TRIALS study record update · 2015-08-07Pilot Study of High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed High-Risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2015-07-29Phase 1 Study on the Use of Racotumomab Anti-idiotype Antibody in Patients With Pediatric Malignancies That Express N-glycolylated Gangliosides and Are Resistant to Conventional Treatment.
-
CLINICAL_TRIALS study record update · 2015-07-16Trial Protocol for the Treatment of Children With High Risk Neuroblastoma (NB2004-HR)
-
CLINICAL_TRIALS study record update · 2015-06-25Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging
-
CLINICAL_TRIALS study record update · 2015-06-11Clinical Application of Intravenous New Castle Disease Virus - HUJ Oncolytic Virus in the Treatment of Advanced Glioblastoma Multiforme, Soft and Bone Sarcomas and Neuroblastoma Patients, Resistant to Conventional Anti- Cancer Modalities
-
CLINICAL_TRIALS study record update · 2015-05-13Observational - Characterizing the Frequency and Spectrum of ALK Mutations in Neuroblastoma